These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 213500)

  • 1. Cell-mediated immunity to murine cytomegalovirus.
    Howard RJ; Mattsson DM; Seidel MV; Balfour HH
    J Infect Dis; 1978 Nov; 138(5):567-604. PubMed ID: 213500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetence.
    Roenhorst HW; Kallenberg CG; The TH
    Clin Exp Immunol; 1988 Dec; 74(3):326-32. PubMed ID: 2853014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Weinberg A; Wohl DA; Barrett RJ; van der Horst C
    J Infect Dis; 2001 Sep; 184(6):707-12. PubMed ID: 11517431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: contribution of CMV-enhanced endothelial ICAM-1.
    Waldman WJ; Knight DA; Huang EH
    J Immunol; 1998 Apr; 160(7):3143-51. PubMed ID: 9531269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.
    Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-cytomegalovirus T-cell immunity and HLA restriction in the transplanted kidney patient].
    Charpentier B; Michelson S; Lantz O; Hiesse C; Martin B; Fries D
    Ann Med Interne (Paris); 1987; 138(5):334-7. PubMed ID: 2823657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
    Fletcher JM; Prentice HG; Grundy JE
    J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulation by cytomegalovirus (CMV): helper T cell-dependent activation of immunoglobulin production in vitro by lymphocytes from CMV-immune donors.
    Yachie A; Tosato G; Straus SE; Blaese RM
    J Immunol; 1985 Aug; 135(2):1395-400. PubMed ID: 2409150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells generated during cytomegalovirus in vitro stimulation of mononuclear cells from HIV-infected individuals on HAART correlate with decreased lymphocyte proliferation.
    Jesser RD; Li S; Weinberg A
    Virology; 2006 Sep; 352(2):408-17. PubMed ID: 16782163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells.
    Lindsley MD; Torpey DJ; Rinaldo CR
    J Immunol; 1986 Apr; 136(8):3045-51. PubMed ID: 2420881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
    Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
    Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells.
    Waldman WJ; Knight DA
    Am J Pathol; 1996 Jan; 148(1):105-19. PubMed ID: 8546198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
    J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infected cells.
    Roenhorst HW; Beelen JM; Middeldorp JM; Schirm J; Tegzess AM; The TH
    Clin Exp Immunol; 1985 Jul; 61(1):72-9. PubMed ID: 2994923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus.
    Reddehase MJ; Keil GM; Koszinowski UH
    J Immunol; 1984 Jan; 132(1):482-9. PubMed ID: 6317749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of cytomegalovirus specific T cells after pediatric allogeneic stem cell transplantation: results from a pilot study using a multi-allele CMV tetramer group.
    Koehl U; Dirkwinkel E; Koenig M; Erben S; Soerensen J; Bader P; Doerr HW; Preiser W; Weissinger E; Klingebiel T; Martin H; Lehrnbecher T
    Klin Padiatr; 2008; 220(6):348-52. PubMed ID: 18949669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of cytomegalovirus-specific cell-mediated immunity in the congenital infection.
    Hayashi N; Kimura H; Morishima T; Tanaka N; Tsurumi T; Kuzushima K
    J Med Virol; 2003 Oct; 71(2):251-8. PubMed ID: 12938200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
    La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
    Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection.
    Roenhorst HW; Middeldorp JM; Beelen JM; Schirm J; Tegzess AM; The TH
    Clin Exp Immunol; 1985 Mar; 59(3):709-15. PubMed ID: 2985307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.